Clinical Trial Update: Assessing the Safety and Ability of SG1002 to Overcome Deficits in Hydrogen Sulfide in Heart Failure Patients [NA]

View source ↗

Summary

Clinical trial update reporting completion and results for SG1002 in heart failure patients, evaluating safety and ability to overcome deficits in hydrogen sulf…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• SG1002

Snippet

Sponsor: Sulfagenix Australia Pty Ltd. | Conditions: Heart Failure | NA | Status: COMPLETED | Results posted: 2020-04-24